review Open AccessTop 1% cited
The resurgence of covalent drugs
Nature Reviews Drug Discovery · 2011 · Vol. 10(4) · pp. 307–317
Juswinder Singh✉Russell C. PetterThomas A. Baillie(Seattle University)Adrian Whitty(Boston University)
Click Chemistry and ApplicationsProtein Degradation and InhibitorsComputational Drug Discovery MethodsCovalent bondDrug discoveryDrugPharmacologyMedicineChemistryBiochemistry
Citations
1,809
FWCI
38.89
field-weighted impact
References
71
Percentile
100%
vs. same field & year
Citations per year
Cited by
Molecular Docking and Structure-Based Drug Design Strategies
Molecules · 2015 · 2,347 citations
The Essential Medicinal Chemistry of Curcumin
Journal of Medicinal Chemistry · 2017 · 1,824 citations
Sulfonyl fluorides as privileged warheads in chemical biology
Chemical Science · 2015 · 528 citations
Development of small-molecule probes that selectively kill cells induced to express mutant RAS
Bioorganic & Medicinal Chemistry Letters · 2011 · 234 citations
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Journal of Pharmacology and Experimental Therapeutics · 2012 · 858 citations
References
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
New England Journal of Medicine · 2001 · 6,459 citations
Identification and Biological Activity of the Active Metabolite of Clopidogrel
Thrombosis and Haemostasis · 2000 · 744 citations
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
PLoS Medicine · 2005 · 3,519 citations
Review article: the clinical pharmacology of proton pump inhibitors
Alimentary Pharmacology & Therapeutics · 2006 · 393 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.